4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-23-004477
Chief Financial Officer bought 5,000 shares at $5.50 ($27,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chardonnet Laurent Chief Financial Officer | 2023-05-23 | Purchase | +5,000 | $5.50 | $27,500 | 42,165 | D |
| Open-market purchases · 5,000 sh · avg $5.50 · $27,500 | |||||||
Loading xslF345X04/primarydocument.xml…